$$UESTION$1$

The following Trial Balances were provided by CORE in Linited for the years ended December $31,2021,$ and December $31,2020.$

CORE $7$ Limited

Thal Ralance

Years Ended December $31,2021$ and $2020.$

i$)$ Closing Stock:

$2020$: $57,000,000$

$2021$: $$6,500,000$

ii$)$ The company has $50,000,000$ ordinary shares issucd and outstanding:

iii$)$ The company ordinary shares craded at $$25$ as at December $31,2020,$ and $$32$ as at December $31,2021.$

$50,400,00$

$=81,250,000,000$

$3,50,$ noo ons

$91,690,000,000$

Required:

Prepare CORE i$7$ Income Seatement for the years ended December $31,2020,$ and December $31,3021.$

$(5$ marks$)$

Prepare CORE in Statement of Financial Position as at December $31,2020,$ whe Dccomber $31.2021.$

$($G masks$)$

For both ycars, computc CORE in's Eamings Per Share $($EPS$)$ and Price Eaning $($PI$)$ Rato.

Q Search

$(4$ marks$)$